About
Stephane Budel
Stephane Budel is a Founding Partner of DeciBio Consulting and one of the firm's leaders in omics-enabled precision medicine. Over the past ~20 years, he has advised many of the companies and investors shaping the future of the space, from sequencing platform innovators and life science tools companies to clinical labs transforming cancer care and private equity firms building platforms across the ecosystem.
His work focuses on the strategic decisions that define where technologies compete, how platforms scale, and which markets are worth building for. Engagements span growth strategy, product and portfolio planning, go-to-market strategy, commercial due diligence, market forecasting, and investor narrative development. Across all of this work, Stephane brings a core belief: the precision medicine revolution will be driven not only by breakthrough therapeutics, but by the tools, diagnostics, data, and workflows that make more precise care possible in the real world.
Stephane is especially passionate about helping leadership teams make decisions where scientific opportunity and commercial reality intersect — and where technical expertise can materially change the answer. His approach combines deep technical fluency with a highly customized view of each client's strategic and market context. Whether evaluating a new sequencing platform, mapping clinical adoption, or pressure-testing an investment thesis, his goal is to help teams move from directional conviction to defensible action that creates enterprise value.
A large part of Stephane's perspective comes from being deeply embedded in the omics ecosystem. Over nearly two decades, he has built trusted relationships with senior executives, founders, investors, and scientific leaders across life science tools and diagnostics — giving him a real-time view into how the category is evolving: how platform companies think, how clinical labs adopt technology, how investors underwrite risk, and where scientific momentum is translating into commercial opportunity. In other words, he spends a lot of time talking to the people building the future of precision medicine — which is a pretty good way to avoid being surprised by it.
At DeciBio, Stephane has helped build the firm's omics practice and continues to shape its vision, culture, partnerships, and external thought leadership. He is a strong believer in entrepreneurship as a core value, a "bias to yes," and the power of bringing the right people together. He regularly convenes executives, investors, founders, and industry leaders across the U.S., Europe, and the U.K. to exchange ideas on the future of diagnostics, tools, and precision medicine — sometimes in conference rooms, often over dinner, and ideally with good wine nearby.
Stephane's perspective is rooted in both scientific training and nearly two decades in strategy consulting. Before founding DeciBio in 2009, he began his consulting career at L.E.K. Consulting. He earned his PhD from Yale University after completing his undergraduate studies in Physiology at the University of Geneva. His scientific training, consulting background, and long tenure in genomics give him a distinctive perspective on how technology markets evolve: where excitement is justified, where adoption will be harder than expected, and where the next wave of value is likely to emerge.
Focus Areas
- Tools and instruments: genomics, proteomics, other omics
- Diagnostics: omics-based Dx, companion diagnostics (CDx), liquid biopsy, etc.
- AI and data in healthcare: diagnostic AI, clinical decision support, lab informatics
Writing Interests
The questions that drive Stephane's writing:
- How do technologies become markets — and why does it take so much longer than it should?
- Why are diagnostics systematically undervalued by markets, payers, and health systems?
- How do tools and diagnostics shape the trajectory of healthcare — and can they yank us into a future where care is preventative?
Stephane can often be found in Los Angeles, London, Paris, or somewhere between meetings in Europe. Outside of work, he is happiest with his family, seeking out excellent coffee, pressed juice, or cheese, discussing novel business ideas, and finding a friendly dog to pet — ideally one that also appreciates precision medicine, though he has learned not to require that.
About This Site
This site is a personal intellectual archive — a place to house essays, field notes, and curated reading on the topics Stephane writes and thinks about. It is not a consulting platform, a commercial advisory service, or a lead-generation site. It is a place to think out loud, with care.
For inquiries, you can reach Stephane via the contact page.